6.6% and 3.9% yields! 2 FTSE 100 stocks I’d snap up for juicy returns

On the hunt for consistent and growing dividends, our writer earmarks these two FTSE 100 stalwarts that could help her achieve that.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young black colleagues high-fiving each other at work

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Two rock-solid FTSE 100 stocks I believe can offer good returns for me and my holdings are GSK (LSE: GSK) and Taylor Wimpey (LSE: TW.).

Here’s why I’d love to buy some shares when I next have some cash to invest.

GSK

As one of the leading names in pharmaceuticals, GSK offers excellent defensive traits, in my view. This is due to the cutting-edge pharma it produces with medicines and treatments to help the world heal from various ailments.

Last month, a judge in Delaware voted in favour of over 70,000 lawsuits to go ahead against the company. This related to GSK’s Zantac drug and its potential links to causing cancer. Although GSK denies any evidence to suggest a risk of cancer, the chance of major fines and reputational damage is a risk I’ll keep an eye on.

From a bullish view, and given the defensive aspects mentioned, I think there’s a lot to like about the business.

To start with, the shares currently trade on a price-to-earnings ratio of 14. It’s also set to go lower, based on forecasts. However, I do understand that forecasts don’t always come to fruition.

Next, GSK shares offer a dividend yield of 3.9%, which is broadly in line with the FTSE 100 average. I can see this dividend growing in the future too, based on the firm’s reputation, experience, and future pipeline. It is worth mentioning that dividends are never guaranteed.

Overall, an established name in the market, an enticing valuation, passive income opportunity, and what looks like a solid R&D pipeline with over 90 products to come, help me make an investment decision today.

Taylor Wimpey

House builders haven’t had a great time of things in the past 12-18 months, due to economic volatility. Higher inflation, interest rates, and a cost-of-living crisis have hurt earnings and sentiment.

Inflation levels are now down, and rumours of a potential interest rate cut could spell good news. A potential housing boom could be on the horizon. However, economic issues are one of the biggest risks for Taylor Wimpey, and something that could dent earnings and returns. For example, higher costs could mean tighter margins and profit levels. I’ll keep an eye on this.

If a housing boom is coming, Taylor Wimpey is primed to benefit. At present, the shares look attractive to me.

Taylor is one of the largest developers in the UK. It possesses a wide presence, as well as plenty of experience and a solid track record. This could serve it well as there is a housing crisis in the UK. With demand outstripping supply, there is an opportunity for the firm to capitalise, and grow earnings and performance.

Finally, the fundamentals look good to me too. Taylor possesses a healthy balance sheet, which can help stave off economic turbulence, as well as support growth. Plus, the shares offer a dividend yield of 6.6% and trade on a P/E ratio of just 14.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

Is the BP share price about to shock us all in 2026?

Can the BP share price perform strongly again next year? Or could the FTSE 100 oil giant be facing a…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

£5,000 put into Nvidia stock could be worth this much by next Christmas…

Nvidia stock is set to rise significantly for the sixth calendar year in seven. But does Wall Street see Nvidia…

Read more »

Investing Articles

Looking for New Year growth stocks? Here’s an epic bargain to discover

This FTSE 250 share has more than doubled in 2025. Here's why our writer believes it remains one of the…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

4 mega-cheap growth shares to consider for 2026!

Discover four top growth shares that our writer Royston Wild thinks may be too cheap to ignore. Could these UK…

Read more »

Tesla car at super charger station
Investing Articles

Can Tesla stock do it again in 2026?

Tesla stock has been on fire (again) in 2025. Might we say the same thing this time next year? Paul…

Read more »

Businessman with tablet, waiting at the train station platform
Dividend Shares

Forecast: the Vodafone share price will pass £1 very soon!

After a tough few years, the Vodafone share price has soared over the past nine months. It's closing on the…

Read more »

Investing Articles

Gold has just smashed record highs and these 3 FTSE stocks are riding the wave

After surging an astonishing 400% in 2025, is this high-flying mining stock still worth checking out in 2026 and beyond?

Read more »

Investing Articles

£10,000 to invest in an ISA? Here are some lesser-known stocks that could surge in 2026

Dr James Fox explores a handful of stocks that could outperform the rest of the stock market in 2026. Investors…

Read more »